Viktor Reshetnikov



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A concept of dual-responsive prodrugs based on oligomerization-controlled reactivity of ester groups: an improvement of cancer cells versus neutrophils selectivity of camptothecin (2024) Klemt I, Reshetnikov V, Dutta S, Bila G, Bilyy R, Cuartero IC, Hidalgo A, et al. Journal article, Original article Cyanine- and Rhodamine-Derived Alkynes for the Selective Targeting of Cancerous Mitochondria through Radical Thiol-Yne Coupling in Live Cells (2023) Köckenberger J, Klemt I, Sauer C, Arkhypov A, Reshetnikov V, Mokhir A, Heinrich M Journal article Intracellular amplifiers of reactive oxygen species affecting mitochondria as radiosensitizers (2022) Xu H, Reshetnikov V, Wondrak M, Eckhardt L, Kunz-Schughart LA, Janko C, Tietze R, et al. Journal article N-Alkylaminoferrocene-Based Prodrugs Targeting Mitochondria of Cancer Cells (2020) Reshetnikov V, Özkan H, Daum S, Janko C, Alexiou C, Sauer C, Heinrich M, Mokhir A Journal article Evaluation of N-alkylaminoferrocenes for in-vivo imaging of reactive oxygen species activity using PET and optical imaging (2019) Toms J, Maschauer S, Daum S, Reshetnikov V, Mokhir A, Prante O Conference contribution Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils (2018) Reshetnikov V, Hahn J, Maueroeder C, Czegley C, Munoz LE, Herrmann M, Hoffmann M, Mokhir A Journal article Radiosynthesis of an 18 F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET (2018) Toms J, Reshetnikov V, Maschauer S, Mokhir A, Prante O Journal article ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria (2018) Reshetnikov V, Daum S, Janko C, Karawacka W, Tietze R, Alexiou C, Paryzhak S, et al. Journal article Lysosome-targeting amplifiers of reactive oxygen species as anticancer prodrugs (2017) Daum S, Reshetnikov V, Sisa M, Dumych T, Lootsik MD, Bilyy R, Bila E, et al. Journal article